Felodipine and Nephropathy - a phase IV clinical study of FDA data

Summary:

Nephropathy is reported as a side effect among people who take Felodipine (felodipine), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Nexium, and have Gastroesophageal reflux disease.

The phase IV clinical study analyzes which people have Nephropathy when taking Felodipine. It is created by eHealthMe based on reports of 14,707 people who have side effects when taking Felodipine from the FDA, and is updated regularly.

What is Felodipine?

Felodipine has active ingredients of felodipine. It is often used in high blood pressure. eHealthMe is studying from 15,120 Felodipine users. Check the latest studies of Felodipine.

What is Nephropathy?

Nephropathy (damage to or disease of a kidney) is found to be associated with 900 drugs and 733 conditions by eHealthMe. Check the latest studies of Nephropathy.

On Jul, 15, 2026

14,707 people reported to have side effects when taking Felodipine.
Among them, 16 people (0.11%) have Nephropathy.

Among these 16 people:

How long have people been on Felodipine when they have Nephropathy? *

What is the gender of people who have Nephropathy when taking Felodipine? *

female: 50 %
male: 50 %

What is the age of people who have Nephropathy when taking Felodipine? *

What are other drugs people take besides Felodipine? *

What are other side effects people have besides Nephropathy? *

Acute Kidney Failure: 13 people, 81.25%
Chronic Kidney Disease: 11 people, 68.75%
Renal Injury (kidney injury): 7 people, 43.75%
Death: 4 people, 25.00%
Nephrogenic Anaemia (anaemia due to kidney disease): 2 people, 12.50%
Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 2 people, 12.50%
Finger Deformity (a deformed position of the finger): 1 person, 6.25%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 1 person, 6.25%
Haemorrhage (bleeding): 1 person, 6.25%
Haemoglobin Decreased: 1 person, 6.25%

What are the existing conditions these people have? *

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 9 people, 56.25%
High Blood Cholesterol: 4 people, 25.00%
Chest Pain: 3 people, 18.75%
Depression: 2 people, 12.50%
Gout (uric acid crystals building up in the body): 2 people, 12.50%
Gastric Ph Decreased: 2 people, 12.50%
Multiple Allergies (allergy to multiple agents): 2 people, 12.50%
Pain: 2 people, 12.50%
Dizziness: 1 person, 6.25%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 6.25%

* Approximation only. Some reports may have incomplete information.

Do you take Felodipine and have Nephropathy?

- Check whether Nephropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Felodipine:

Felodipine (15,120 reports)

Nephropathy treatments and more:

Nephropathy (16,529 reports)

Browse all side effects of Felodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nephropathy:

Nephropathy (900 drugs)

Browse all the conditions that are associated with Nephropathy:

Nephropathy (733 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on felodipine (the active ingredients of Felodipine) and Felodipine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.